Why Is Altimmune (ALT) Stock Up 14% Today?

Altimmune stock is rising higher on Monday as ALT investors react to positive news from rival weight loss drugmaker Zealand Pharma.

Altimmune Inc. (ALT stock) - Bad Drug Trial News Weighs it Down - The Coin Republic

Why Is Altimmune (ALT) Stock Up 14% Today?

Call Traders Targeting Rallying Weight-Loss Drug Developer

34 Stocks Moving in Friday's Pre-Market Session - Altimmune (NASDAQ:ALT), Senmiao Tech (NASDAQ:AIHS) - Benzinga

Altimmune (ALT) Price Target Increased by 16.42% to 22.73

Investing Insights & Market Analysis [Issue #23: Week 50, December 2023]

Analyst Ratings for Altimmune

Altimmune Inc (ALT) Down 0.87% in Premarket Trading

Stock market today: Live updates

Altimmune Stock News (ALT)

Altimmune (ALT) - 6 Price Charts 2005-2024 (History)

Is Altimmune (ALT) stock a good buy after the 306% jump?

Altimmune Inc (ALT) is down 3.79% Monday In Premarket Trading

SNN

Altimmune gets FDA nod to start clinical trials for intranasal Covid-19 vaccine - Washington Business Journal